SCHEMBL948938

SCHEMBL948938

CC(C)(C)c1cc(OP(Oc2cc(C(C)(C)C)cc(C(C)(C)C)c2)Oc2cc(C(C)(C)C)cc(C(C)(C)C)c2)cc(C(C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 1/20 0.44
▸ GABRB2 P47870 1/20 0.44
▸ POLB P06746 1/20 0.36
▸ TSHR P16473 1/20 0.35
▸ MAPT P10636 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ RXRA P19793 1/20 0.31
▸ RXRB P28702 1/20 0.31
▸ RXRG P48443 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ HPGD P15428 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ HTR1D P28221 1/20 0.31
▸ HMGCR P04035 2/20 0.31
▸ ALOX15 P16050 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9445182 0.82 GABRA1 (0.30) GABRA1GABRB2
SCHEMBL28394865 0.81 GABRA1 (0.46) GABRA1GABRB2POLBMAPTKDM4E
SCHEMBL9241814 0.81 GABRA1 (0.46) GABRA1GABRB2POLBMAPTKDM4E
SCHEMBL16181674 0.80 CA1 (0.35) GABRA1GABRB2TSHRMAPTKDM4E
SCHEMBL561428 0.78 CYP3A4 (0.46) POLBTSHRMAPTRXRARXRB
SCHEMBL28990026 0.76 GABRA1 (0.41) GABRA1GABRB2POLBRXRARXRB
SCHEMBL72636 0.75 TSHR (0.52) POLBTSHRMAPTKDM4EALDH1A1
SCHEMBL93161 0.74 GABRA1 (0.69) GABRA1GABRB2POLBTSHRMAPT
SCHEMBL3807248 0.74 ALDH1A1 (0.53) GABRA1GABRB2POLBMAPTKDM4E
SCHEMBL11677895 0.73 TSHR (0.50) POLBTSHRMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114690559-A Photosensitive resin composition, cured film and display device 株式会社东进世美肯 2022-07-01 — — CN disclosed
US-11352324-B2 Methods MEDIMMUNE LIMITED (GB) 2022-06-07 — — US disclosed
US-20200399215-A1 METHODS MEDIMMUNE LIMITED (GB) 2020-12-24 — — US disclosed
US-7875686-B2 comprising 10 to 99 wt. % of norbornene-type cycloolefin monomers; for microelectronic, optoelectronic and micro-optoelectronic applications such as die attach adhesives, underfill materials, prepreg binders, encapsulants PROMERUS LLC (US) 2011-01-25 — — US disclosed
US-7534539-B2 Electrophotographic photoreceptor and image forming apparatus having the same SHARP KABUSHIKI KAISHA (JP) 2009-05-19 — — US disclosed
EP-1791888-B1 POLYCYCLOOLEFIN POLYMERIC COMPOSITIONS FOR SEMICONDUCTOR APPLICATIONS PROMERUS LLC (US) 2009-03-25 — — EP disclosed
EP-1791888-A1 POLYCYCLOOLEFIN POLYMERIC COMPOSITIONS FOR SEMICONDUCTOR APPLICATIONS Promerus, LLC (US) 2007-06-06 — — EP disclosed
WO-2006023511-A1 POLYCYCLOOLEFIN POLYMERIC COMPOSITIONS FOR SEMICONDUCTOR APPLICATIONS PROMERUS LLC (US) 2006-03-02 — — WO disclosed
US-20060041093-A1 Polycycloolefin polymeric compositions for semiconductor applications SUMITOMO BAKELITE CO., LTD. (JP) 2006-02-23 — — US disclosed
EP-0517843-A1 POLYUREA GEL COMPOSITIONS AND ARTICLES THEREFROM RAYCHEM CORPORATION (US) 1992-12-16 — — EP disclosed
US-5104930-A Sealing and protecting substrates; tensile strength, elongation, toughness, compatibility RAYCHEM CORPORATION (US) 1992-04-14 — — US disclosed
WO-1991013109-A1 POLYUREA GEL COMPOSITIONS AND ARTICLES THEREFROM RAYCHEM CORPORATION (US) 1991-09-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352324-B2 Methods SIN3A, RCC2, RPS3 GABRA1 3687/4885GABRB2 2834/4885POLB 1821/4885
US-20200399215-A1 METHODS SIN3A, RCC2, RPS3 GABRA1 3687/4885GABRB2 2834/4885POLB 1821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback